Skip to content
GALVmed
-
GALVmed, universities, Biovet advance next-generation HS vaccine to strengthen livestock health and productivity
The partnership will see Biovet lead safety, efficacy, and field trials, as well as the process toward market authorisation, while GALVmed supports downstream development and deployment.
-
Africa moves to strengthen veterinary product regulation
Fragmented regulatory systems, coupled with challenges such as inadequate cold-chain infrastructure, continue to hinder veterinary solutions.
-
Lois Muraguri appointed CEO of GALVmed, pledges smarter collaboration for sustainable animal health
GALVmed works to make livestock vaccines and medicines more accessible, particularly in sub-Saharan Africa.
-
Pirbright, GALVmed partner to develop new Rift Valley fever vaccine
The Pirbright Institute is a world-leading research and surveillance center for viral diseases of livestock and viruses that spread from animals to humans.
-
